FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Caroline Demacq

Research Profile

Chemicals & Drugs

Disorders

Physiology

Concepts & Ideas

Procedures

Blood Pressure Monitoring, Ambulatory

Geographic Areas

Brazil

Co-author Network

Publications

TOP 3
C de Haro Moraes; Caroline Demacq; Sílvia Elaine Ferreira-Melo; V N Figueiredo; N R Barbaro; A P C de Faria; L C Martins; T Quinaglia; A R Sabbatini; H M Júnior
High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension.
Leandro Boer-Martins; Caroline Demacq; Ana Paula Cabral de Faria; Valéria Nasser Figueiredo; Luiz Cláudio Martins; Carolina de Haro Moraes; Heitor Moreno
Leptin and aldosterone in sympathetic activity in resistant hypertension with or without type 2 diabetes.
T Quinaglia; R C Santos; Juan Carlos Yugar-Toledo; Eduardo Pimenta; D A Calhoun; Caroline Demacq; V N Figueiredo; J F Vilela Martin; L C Martins; H Moreno
Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Caroline Demacq (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: C de Haro Moraes; Caroline Demacq; Sílvia Elaine Ferreira-Melo; V N Figueiredo; N R Barbaro; A P C de Faria; L C Martins; T Quinaglia; A R Sabbatini; H M Júnior
High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension.
Journal of human hypertension 2013;27(4):225-30.
2012: Leandro Boer-Martins; Caroline Demacq; Ana Paula Cabral de Faria; Valéria Nasser Figueiredo; Luiz Cláudio Martins; Carolina de Haro Moraes; Heitor Moreno
Leptin and aldosterone in sympathetic activity in resistant hypertension with or without type 2 diabetes.
Arquivos brasileiros de cardiologia 2012;99(1):642-8.
2011: T Quinaglia; R C Santos; Juan Carlos Yugar-Toledo; Eduardo Pimenta; D A Calhoun; Caroline Demacq; V N Figueiredo; J F Vilela Martin; L C Martins; H Moreno
Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension.
Journal of human hypertension 2011;25(11):656-64.
2011: L C Martins; E Pimenta; T Quinaglia; Juan Carlos Yugar-Toledo; L Boer-Martins; D A Calhoun; Caroline Demacq; V N Figueiredo; J F V Martin; H Moreno
Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness.
Journal of human hypertension 2011;25(9):532-8.
2011: Juan Carlos Yugar-Toledo; David A Calhoun; Otávio Rizzi Coelho; Caroline Demacq; José Eduardo Krieger; José Fernando Vilela Martin; Alexandre C Pereira; Eduardo Pimenta; Heitor Moreno Júnior
Gene variation in resistant hypertension: multilocus analysis of the angiotensin 1-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase genes.
DNA and cell biology 2011;30(8):555-64.
2011: Silvia Elaine Ferreira-Melo; Maria Cláudia Irigoyen; José Eduardo Krieger; Silvia Lacchini; Caroline Demacq; Heitor Moreno
Sildenafil preserves diastolic relaxation after reduction by L-NAME and increases phosphodiesterase-5 in the intercalated discs of cardiac myocytes and arterioles.
Clinics (São Paulo, Brazil) 2011;66(7):1253-8.
2011: Leandro Boer-Martins; Valéria N Figueiredo; Caroline Demacq; Luiz C Martins; Fernanda Consolin-Colombo; Márcio J Figueiredo; Fernando P S Cannavan; Heitor Moreno
Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients.
Cardiovascular diabetology 2011;10():24.
2010: Caroline Demacq; Vivian B Vasconcellos; Tatiane de Carvalho Izidoro-Toledo; Vanessa da Silva Silveira; Renata Canalle; Rosane Gomes de Paula Queiroz; Luiz Gonzaga Tone; Jose E Tanus-Santos
Vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (NOS3) polymorphisms are associated with high relapse risk in childhood acute lymphoblastic leukemia (ALL).
Clinica chimica acta; international journal of clinical chemistry 2010;411(17-18):1335-40.
2009: Caroline Demacq; V B Vasconcellos; A M Marcaccini; Raquel F Gerlach; A A Machado; Jose E Tanus-Santos
A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients.
The pharmacogenomics journal 2009;9(4):265-73.
2008: ML Martinez; Michele M Castro; Elen Rizzi; Karla Fernandes; Caroline Demacq; Lusiane M Bendhack; Raquel F Gerlach; Jose E Tanus-Santos
Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
European journal of pharmacology 2008;591(1-3):224-30.
2008: Caroline Demacq; Ingrid F Metzger; Raquel F Gerlach; Jose E Tanus-Santos
Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers.
Clinica chimica acta; international journal of clinical chemistry 2008;394(1-2):72-6.
2008: Caroline Demacq; Vivian B Vasconcellos; Andrea M Marcaccini; Raquel F Gerlach; Wilson Araújo Silva Jr; Jose E Tanus-Santos
Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2008;46(1):57-63.
2007: Raquel F Gerlach; Caroline Demacq; Klaus Jung; Jose E Tanus-Santos
Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma.
Clinical biochemistry 2007;40(1-2):119-23.
2006: Caroline Demacq; Ana Paula de Souza; Alcyone Artioli Machado; Raquel F Gerlach; Jose E Tanus-Santos
Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects.
Clinica chimica acta; international journal of clinical chemistry 2006;365(1-2):183-7.
2006: Caroline Demacq; Marcelo F Montenegro
Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2006;44(2):232; author reply 233.
2006: Caroline Demacq
Circulating matrix metalloproteinase-9 levels and alteplase treatment.
Thrombosis research 2006;118(4):543.